These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2931063)
1. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy. Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA Arch Ophthalmol; 1985 Sep; 103(9):1307-11. PubMed ID: 2931063 [TBL] [Abstract][Full Text] [Related]
2. Effect of sorbinil on blood-retinal barrier in early diabetic retinopathy. Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA Diabetes; 1986 May; 35(5):574-8. PubMed ID: 3514333 [TBL] [Abstract][Full Text] [Related]
3. Blood-retina barrier permeability in diabetes during acute ACE-inhibition. Engler CB; Parving HH; Mathiesen ER; Larsen M; Lund-Andersen H Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410 [TBL] [Abstract][Full Text] [Related]
4. Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial. van Gerven JM; Boot JP; Lemkes HH; van Best JA Doc Ophthalmol; 1994; 87(4):355-65. PubMed ID: 7851219 [TBL] [Abstract][Full Text] [Related]
5. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry. Schalnus R; Ohrloff C Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448 [TBL] [Abstract][Full Text] [Related]
6. Posterior vitreous fluorophotometry in diabetic patients with minimal or no retinopathy. Roy MS; Podgor MJ; Bungay P; Grunberger G; Carl J; Ellis D Retina; 1987; 7(3):170-6. PubMed ID: 3423432 [TBL] [Abstract][Full Text] [Related]
7. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study. Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM Retina; 1995; 15(2):134-40. PubMed ID: 7624601 [TBL] [Abstract][Full Text] [Related]
8. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy. Yoshida A; Kojima M; Ogasawara H; Ishiko S Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365 [TBL] [Abstract][Full Text] [Related]
9. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy. Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779 [TBL] [Abstract][Full Text] [Related]
10. Quantitative vitreous fluorophotometry. A sensitive technique for measuring early breakdown of the blood-retinal barrier in young diabetic patients. Waltman SR; Oestrich C; Krupin T; Hanish S; Ratzan S; Santiago J; Kilo C Diabetes; 1978 Feb; 27(2):85-7. PubMed ID: 624444 [TBL] [Abstract][Full Text] [Related]
12. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy. Leite EB; Mota MC; de Abreu JR; Cunha-Vaz JG Int Ophthalmol; 1990 Mar; 14(2):81-8. PubMed ID: 2187006 [TBL] [Abstract][Full Text] [Related]
14. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study. Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG; Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797 [TBL] [Abstract][Full Text] [Related]
15. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine. Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399 [TBL] [Abstract][Full Text] [Related]
16. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry. Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099 [TBL] [Abstract][Full Text] [Related]
17. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy. Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598 [TBL] [Abstract][Full Text] [Related]
18. Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes. Cunha-Vaz JG Diabetes; 1983 May; 32 Suppl 2():20-7. PubMed ID: 6400666 [TBL] [Abstract][Full Text] [Related]
19. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Parving HH; Larsen M; Hommel E; Lund-Andersen H Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698 [TBL] [Abstract][Full Text] [Related]
20. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study. Engler C; Krogsaa B; Lund-Andersen H Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):442-6. PubMed ID: 1937077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]